Waterfall plot analysis comparing tumor volumes at start and treatment end point revealed great reduction of tumor volumes in the olaparib-treated INPP4B-deficient cohort in contrast to the control cohort, which exhibited little to moderate response to treatment (Figure 4B). The gene discussed is INPP4B; the disease is neoplasm.